TQC3927 inhalation aerosol

SUSPENDED · PHASE2 · Chronic Obstructive Pulmonary Disease

The sponsor has decided to suspend study progress. Further implementation of the study is pending notification.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.